henhaobio
Sign in

CellsMolecular BiologyPeer-reviewed journal article

A live cell protein complementation assay for ORFeome-wide probing of human HOX interactomes

Yunlong Y. JiaiD, Jonathan RebouletiD, Benjamin GilletiD, Sandrine HughesiD, Christelle ForcetiD, Violaine Tribollet, Nawal Hajj SleimaniD, Cindy KundlacziD, Jean-Marc VanackeriD, Françoise BleicheriD, Samir MerabetiD

PDFDOIPreprint

Abstract

Biological pathways rely on the formation of intricate protein interaction networks called interactomes. Getting a comprehensive map of interactomes implies developing tools that allow capturing transient and low affinity protein-protein interactions (PPIs) in live conditions. Here we present an experimental strategy, Cell-PCA (Cell Protein Complementation Assay), which is based on BiFC (Bimolecular Fluorescence Complementation) and high throughput sequencing for ORFeome-wide analyses of different interactomes in the same live cell context. The specificity and sensitivity of Cell-PCA was established by using a wild type and a single amino-acid mutated HOXA9 protein, and the approach was subsequently applied for seven additional human HOX proteins. These proof-of-concept experiments revealed novel molecular properties of HOX interactomes and led to the identification of a novel cofactor of HOXB13 for promoting its proliferative activity in a cancer cell context. Taken together, our work demonstrates that Cell-PCA is pertinent for revealing and, importantly, comparing interactomes between different or highly related bait proteins in the same cell context.

Citations
10
FWCI
0.89
Field percentile
top 32%

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISChen '26Serebryanny '18Huttlin '21Evans-Yamam '22Bakhtina '24Skinnider '18
55% semantic matchBiochemistry
Zhi Chen, István Szepesi-Nagy, Qingyue Zhang+13 more·bioRxiv·Jul 17, 2026